nodes	percent_of_prediction	percent_of_DWPC	metapath
Thioridazine—CHRM2—type 1 diabetes mellitus	0.802	1	CbGaD
Thioridazine—HTR7—umbilical artery—type 1 diabetes mellitus	0.0199	0.269	CbGeAlD
Thioridazine—HTR2A—arteriole—type 1 diabetes mellitus	0.00713	0.0965	CbGeAlD
Thioridazine—HTR7—autonomic nervous system—type 1 diabetes mellitus	0.0049	0.0663	CbGeAlD
Thioridazine—DRD1—nerve—type 1 diabetes mellitus	0.00441	0.0597	CbGeAlD
Thioridazine—HTR7—peripheral nervous system—type 1 diabetes mellitus	0.00353	0.0478	CbGeAlD
Thioridazine—HTR2A—autonomic nervous system—type 1 diabetes mellitus	0.00306	0.0413	CbGeAlD
Thioridazine—HTR7—nerve—type 1 diabetes mellitus	0.00276	0.0373	CbGeAlD
Thioridazine—DRD2—nerve—type 1 diabetes mellitus	0.00261	0.0353	CbGeAlD
Thioridazine—ADRA2A—peripheral nervous system—type 1 diabetes mellitus	0.00259	0.0351	CbGeAlD
Thioridazine—HTR2A—peripheral nervous system—type 1 diabetes mellitus	0.0022	0.0298	CbGeAlD
Thioridazine—HTR2A—nerve—type 1 diabetes mellitus	0.00172	0.0233	CbGeAlD
Thioridazine—ADRA1B—kidney—type 1 diabetes mellitus	0.00162	0.0219	CbGeAlD
Thioridazine—CHRM2—cardiovascular system—type 1 diabetes mellitus	0.00125	0.0168	CbGeAlD
Thioridazine—KCNH2—islet of Langerhans—type 1 diabetes mellitus	0.00124	0.0168	CbGeAlD
Thioridazine—DRD2—retina—type 1 diabetes mellitus	0.00108	0.0146	CbGeAlD
Thioridazine—HTR1A—cardiovascular system—type 1 diabetes mellitus	0.00101	0.0137	CbGeAlD
Thioridazine—ADRA2A—islet of Langerhans—type 1 diabetes mellitus	0.000979	0.0132	CbGeAlD
Thioridazine—HTR7—cardiovascular system—type 1 diabetes mellitus	0.000965	0.0131	CbGeAlD
Thioridazine—HTR7—kidney—type 1 diabetes mellitus	0.000945	0.0128	CbGeAlD
Thioridazine—ADRA1A—cardiovascular system—type 1 diabetes mellitus	0.000931	0.0126	CbGeAlD
Thioridazine—KCNH2—cardiovascular system—type 1 diabetes mellitus	0.000899	0.0122	CbGeAlD
Thioridazine—Cyamemazine—CHRM2—type 1 diabetes mellitus	0.000838	0.109	CrCbGaD
Thioridazine—CYP2C8—kidney—type 1 diabetes mellitus	0.000805	0.0109	CbGeAlD
Thioridazine—ADRA1A—lymphoid tissue—type 1 diabetes mellitus	0.000783	0.0106	CbGeAlD
Thioridazine—Metixene—CHRM2—type 1 diabetes mellitus	0.000779	0.101	CrCbGaD
Thioridazine—CYP2E1—nephron tubule—type 1 diabetes mellitus	0.000771	0.0104	CbGeAlD
Thioridazine—CYP2C9—cardiovascular system—type 1 diabetes mellitus	0.000731	0.00989	CbGeAlD
Thioridazine—Mequitazine—CHRM2—type 1 diabetes mellitus	0.000728	0.0943	CrCbGaD
Thioridazine—HTR2A—retina—type 1 diabetes mellitus	0.000712	0.00963	CbGeAlD
Thioridazine—Ethopropazine—CHRM2—type 1 diabetes mellitus	0.00071	0.0921	CrCbGaD
Thioridazine—CYP2E1—cardiovascular system—type 1 diabetes mellitus	0.000693	0.00937	CbGeAlD
Thioridazine—ADRA2A—pancreas—type 1 diabetes mellitus	0.000688	0.00931	CbGeAlD
Thioridazine—CYP2E1—kidney—type 1 diabetes mellitus	0.000678	0.00917	CbGeAlD
Thioridazine—HTR2A—cardiovascular system—type 1 diabetes mellitus	0.000602	0.00815	CbGeAlD
Thioridazine—HTR2A—kidney—type 1 diabetes mellitus	0.000589	0.00797	CbGeAlD
Thioridazine—CYP2E1—lymphoid tissue—type 1 diabetes mellitus	0.000582	0.00788	CbGeAlD
Thioridazine—Triflupromazine—CHRM2—type 1 diabetes mellitus	0.000582	0.0754	CrCbGaD
Thioridazine—CYP2D6—kidney—type 1 diabetes mellitus	0.000537	0.00726	CbGeAlD
Thioridazine—Mesoridazine—CHRM2—type 1 diabetes mellitus	0.000511	0.0662	CrCbGaD
Thioridazine—Prochlorperazine—CHRM2—type 1 diabetes mellitus	0.000495	0.0641	CrCbGaD
Thioridazine—Propiomazine—CHRM2—type 1 diabetes mellitus	0.00043	0.0558	CrCbGaD
Thioridazine—Methotrimeprazine—CHRM2—type 1 diabetes mellitus	0.000368	0.0477	CrCbGaD
Thioridazine—Promethazine—CHRM2—type 1 diabetes mellitus	0.000362	0.047	CrCbGaD
Thioridazine—Trifluoperazine—CHRM2—type 1 diabetes mellitus	0.000358	0.0464	CrCbGaD
Thioridazine—Promazine—CHRM2—type 1 diabetes mellitus	0.000319	0.0413	CrCbGaD
Thioridazine—Chlorpromazine—CHRM2—type 1 diabetes mellitus	0.000281	0.0364	CrCbGaD
Thioridazine—Acepromazine—ALB—type 1 diabetes mellitus	0.000184	0.0239	CrCbGaD
Thioridazine—Thioproperazine—ALB—type 1 diabetes mellitus	0.00018	0.0234	CrCbGaD
Thioridazine—Thiothixene—ALB—type 1 diabetes mellitus	0.000177	0.023	CrCbGaD
Thioridazine—Pipotiazine—ALB—type 1 diabetes mellitus	0.000177	0.023	CrCbGaD
Thioridazine—Clomipramine—ALB—type 1 diabetes mellitus	0.00014	0.0182	CrCbGaD
Thioridazine—Gynaecomastia—Ramipril—type 1 diabetes mellitus	0.000102	0.0528	CcSEcCtD
Thioridazine—Chlorpromazine—ALB—type 1 diabetes mellitus	9.61e-05	0.0125	CrCbGaD
Thioridazine—Photosensitivity—Ramipril—type 1 diabetes mellitus	9.42e-05	0.0488	CcSEcCtD
Thioridazine—Nasal congestion—Ramipril—type 1 diabetes mellitus	9.08e-05	0.047	CcSEcCtD
Thioridazine—Dermatitis exfoliative—Ramipril—type 1 diabetes mellitus	8.77e-05	0.0454	CcSEcCtD
Thioridazine—Asthma—Ramipril—type 1 diabetes mellitus	7.15e-05	0.037	CcSEcCtD
Thioridazine—Eosinophilia—Ramipril—type 1 diabetes mellitus	7.08e-05	0.0367	CcSEcCtD
Thioridazine—Sweating increased—Ramipril—type 1 diabetes mellitus	6.97e-05	0.0361	CcSEcCtD
Thioridazine—Pancytopenia—Ramipril—type 1 diabetes mellitus	6.79e-05	0.0352	CcSEcCtD
Thioridazine—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	6.53e-05	0.0338	CcSEcCtD
Thioridazine—Weight increased—Ramipril—type 1 diabetes mellitus	6.51e-05	0.0337	CcSEcCtD
Thioridazine—Jaundice—Ramipril—type 1 diabetes mellitus	6.22e-05	0.0322	CcSEcCtD
Thioridazine—Agranulocytosis—Ramipril—type 1 diabetes mellitus	5.95e-05	0.0308	CcSEcCtD
Thioridazine—Oedema peripheral—Ramipril—type 1 diabetes mellitus	5.64e-05	0.0292	CcSEcCtD
Thioridazine—Arrhythmia—Ramipril—type 1 diabetes mellitus	5.11e-05	0.0265	CcSEcCtD
Thioridazine—Mental disorder—Ramipril—type 1 diabetes mellitus	5.02e-05	0.026	CcSEcCtD
Thioridazine—Erythema—Ramipril—type 1 diabetes mellitus	4.98e-05	0.0258	CcSEcCtD
Thioridazine—Tremor—Ramipril—type 1 diabetes mellitus	4.67e-05	0.0242	CcSEcCtD
Thioridazine—Agitation—Ramipril—type 1 diabetes mellitus	4.58e-05	0.0237	CcSEcCtD
Thioridazine—Angioedema—Ramipril—type 1 diabetes mellitus	4.55e-05	0.0236	CcSEcCtD
Thioridazine—Leukopenia—Ramipril—type 1 diabetes mellitus	4.46e-05	0.0231	CcSEcCtD
Thioridazine—Confusional state—Ramipril—type 1 diabetes mellitus	4.1e-05	0.0212	CcSEcCtD
Thioridazine—Oedema—Ramipril—type 1 diabetes mellitus	4.07e-05	0.0211	CcSEcCtD
Thioridazine—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	3.98e-05	0.0206	CcSEcCtD
Thioridazine—Tachycardia—Ramipril—type 1 diabetes mellitus	3.97e-05	0.0206	CcSEcCtD
Thioridazine—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	3.93e-05	0.0204	CcSEcCtD
Thioridazine—Anorexia—Ramipril—type 1 diabetes mellitus	3.88e-05	0.0201	CcSEcCtD
Thioridazine—Hypotension—Ramipril—type 1 diabetes mellitus	3.8e-05	0.0197	CcSEcCtD
Thioridazine—Somnolence—Ramipril—type 1 diabetes mellitus	3.62e-05	0.0187	CcSEcCtD
Thioridazine—Decreased appetite—Ramipril—type 1 diabetes mellitus	3.54e-05	0.0183	CcSEcCtD
Thioridazine—Constipation—Ramipril—type 1 diabetes mellitus	3.48e-05	0.018	CcSEcCtD
Thioridazine—Feeling abnormal—Ramipril—type 1 diabetes mellitus	3.35e-05	0.0174	CcSEcCtD
Thioridazine—Body temperature increased—Ramipril—type 1 diabetes mellitus	3.22e-05	0.0167	CcSEcCtD
Thioridazine—Hypersensitivity—Ramipril—type 1 diabetes mellitus	3e-05	0.0155	CcSEcCtD
Thioridazine—Diarrhoea—Ramipril—type 1 diabetes mellitus	2.78e-05	0.0144	CcSEcCtD
Thioridazine—Vomiting—Ramipril—type 1 diabetes mellitus	2.59e-05	0.0134	CcSEcCtD
Thioridazine—Rash—Ramipril—type 1 diabetes mellitus	2.56e-05	0.0133	CcSEcCtD
Thioridazine—Dermatitis—Ramipril—type 1 diabetes mellitus	2.56e-05	0.0133	CcSEcCtD
Thioridazine—Headache—Ramipril—type 1 diabetes mellitus	2.55e-05	0.0132	CcSEcCtD
Thioridazine—Nausea—Ramipril—type 1 diabetes mellitus	2.42e-05	0.0125	CcSEcCtD
Thioridazine—HTR7—Signaling Pathways—INS—type 1 diabetes mellitus	1.5e-05	0.000132	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.5e-05	0.000131	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.47e-05	0.000129	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—GCG—type 1 diabetes mellitus	1.47e-05	0.000129	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.47e-05	0.000129	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.47e-05	0.000129	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.46e-05	0.000128	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.45e-05	0.000128	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.45e-05	0.000127	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.45e-05	0.000127	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.45e-05	0.000127	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.45e-05	0.000127	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.45e-05	0.000127	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.45e-05	0.000127	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.45e-05	0.000127	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.45e-05	0.000127	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—CAT—type 1 diabetes mellitus	1.44e-05	0.000127	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.44e-05	0.000127	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.44e-05	0.000127	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.44e-05	0.000127	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.43e-05	0.000125	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.42e-05	0.000125	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.42e-05	0.000125	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.42e-05	0.000125	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.42e-05	0.000125	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.42e-05	0.000124	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CD86—type 1 diabetes mellitus	1.41e-05	0.000124	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.41e-05	0.000124	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—ITPR3—type 1 diabetes mellitus	1.4e-05	0.000123	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.4e-05	0.000123	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.4e-05	0.000123	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CD86—type 1 diabetes mellitus	1.39e-05	0.000122	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.39e-05	0.000122	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CD86—type 1 diabetes mellitus	1.39e-05	0.000122	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.39e-05	0.000122	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.38e-05	0.000121	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—CD80—type 1 diabetes mellitus	1.37e-05	0.00012	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CD86—type 1 diabetes mellitus	1.37e-05	0.00012	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CD86—type 1 diabetes mellitus	1.36e-05	0.00012	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.36e-05	0.000119	CbGpPWpGaD
Thioridazine—DRD2—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.35e-05	0.000119	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.34e-05	0.000118	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.34e-05	0.000118	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.34e-05	0.000118	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.34e-05	0.000118	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.33e-05	0.000117	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.33e-05	0.000117	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.33e-05	0.000116	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.32e-05	0.000116	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.32e-05	0.000116	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—HBA1—type 1 diabetes mellitus	1.32e-05	0.000116	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.32e-05	0.000116	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—GCG—type 1 diabetes mellitus	1.32e-05	0.000116	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.32e-05	0.000115	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.32e-05	0.000115	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.31e-05	0.000115	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—APOC3—type 1 diabetes mellitus	1.31e-05	0.000115	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.31e-05	0.000115	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.3e-05	0.000114	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.3e-05	0.000114	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.29e-05	0.000114	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—INS—type 1 diabetes mellitus	1.29e-05	0.000113	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—GSTT1—type 1 diabetes mellitus	1.29e-05	0.000113	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.28e-05	0.000112	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CD86—type 1 diabetes mellitus	1.27e-05	0.000111	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.26e-05	0.00011	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.25e-05	0.00011	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.25e-05	0.00011	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.25e-05	0.00011	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—CAT—type 1 diabetes mellitus	1.25e-05	0.00011	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.24e-05	0.000109	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.24e-05	0.000109	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.23e-05	0.000108	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.23e-05	0.000108	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.23e-05	0.000108	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.23e-05	0.000108	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.23e-05	0.000108	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.22e-05	0.000107	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.21e-05	0.000107	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.21e-05	0.000106	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	1.21e-05	0.000106	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.21e-05	0.000106	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.21e-05	0.000106	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.21e-05	0.000106	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.2e-05	0.000106	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.2e-05	0.000105	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—GCG—type 1 diabetes mellitus	1.2e-05	0.000105	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.19e-05	0.000105	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.19e-05	0.000105	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.19e-05	0.000104	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.19e-05	0.000104	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.18e-05	0.000104	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—CD80—type 1 diabetes mellitus	1.18e-05	0.000103	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—CD80—type 1 diabetes mellitus	1.17e-05	0.000103	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.15e-05	0.000101	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.14e-05	0.0001	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.13e-05	9.94e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.12e-05	9.86e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—CD80—type 1 diabetes mellitus	1.12e-05	9.82e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.12e-05	9.8e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.12e-05	9.79e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—IL2—type 1 diabetes mellitus	1.12e-05	9.79e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—CAT—type 1 diabetes mellitus	1.11e-05	9.78e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—IL2—type 1 diabetes mellitus	1.11e-05	9.78e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—INS—type 1 diabetes mellitus	1.11e-05	9.75e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.11e-05	9.74e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.11e-05	9.73e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.11e-05	9.71e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—INS—type 1 diabetes mellitus	1.1e-05	9.7e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.1e-05	9.64e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.07e-05	9.43e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.07e-05	9.38e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.07e-05	9.38e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.06e-05	9.33e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—INS—type 1 diabetes mellitus	1.06e-05	9.28e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—INS—type 1 diabetes mellitus	1.04e-05	9.16e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CD80—type 1 diabetes mellitus	1.03e-05	9.06e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—GCG—type 1 diabetes mellitus	1.03e-05	9e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	1.02e-05	8.99e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.02e-05	8.98e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.02e-05	8.93e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—CAT—type 1 diabetes mellitus	1.02e-05	8.92e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CD80—type 1 diabetes mellitus	1.02e-05	8.91e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CD80—type 1 diabetes mellitus	1.01e-05	8.89e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CD80—type 1 diabetes mellitus	9.97e-06	8.75e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CD80—type 1 diabetes mellitus	9.94e-06	8.73e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	9.92e-06	8.71e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—TYK2—type 1 diabetes mellitus	9.87e-06	8.66e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—INS—type 1 diabetes mellitus	9.75e-06	8.56e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	9.74e-06	8.55e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—NOS3—type 1 diabetes mellitus	9.69e-06	8.5e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—CASP3—type 1 diabetes mellitus	9.62e-06	8.44e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—IL2—type 1 diabetes mellitus	9.6e-06	8.43e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—INS—type 1 diabetes mellitus	9.6e-06	8.42e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—INS—type 1 diabetes mellitus	9.59e-06	8.41e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—INS—type 1 diabetes mellitus	9.57e-06	8.4e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—ALB—type 1 diabetes mellitus	9.57e-06	8.4e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—IL6—type 1 diabetes mellitus	9.55e-06	8.38e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—TYK2—type 1 diabetes mellitus	9.45e-06	8.29e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—IGF1—type 1 diabetes mellitus	9.43e-06	8.28e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—INS—type 1 diabetes mellitus	9.42e-06	8.27e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—INS—type 1 diabetes mellitus	9.4e-06	8.24e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—STAT3—type 1 diabetes mellitus	9.39e-06	8.24e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	9.39e-06	8.24e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—STAT3—type 1 diabetes mellitus	9.38e-06	8.23e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	9.28e-06	8.14e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—NOS3—type 1 diabetes mellitus	9.28e-06	8.14e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IGF1—type 1 diabetes mellitus	9.26e-06	8.13e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CD80—type 1 diabetes mellitus	9.24e-06	8.11e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	9.23e-06	8.1e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	9.21e-06	8.09e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—NOS3—type 1 diabetes mellitus	9.16e-06	8.03e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IGF1—type 1 diabetes mellitus	9.11e-06	8e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	9.09e-06	7.97e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	9.07e-06	7.96e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	9.04e-06	7.94e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—ALB—type 1 diabetes mellitus	8.79e-06	7.71e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—INS—type 1 diabetes mellitus	8.73e-06	7.66e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—TYK2—type 1 diabetes mellitus	8.71e-06	7.65e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—CAT—type 1 diabetes mellitus	8.68e-06	7.62e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	8.57e-06	7.52e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—TYK2—type 1 diabetes mellitus	8.55e-06	7.51e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—NOS3—type 1 diabetes mellitus	8.55e-06	7.5e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—EGFR—type 1 diabetes mellitus	8.53e-06	7.49e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—EGFR—type 1 diabetes mellitus	8.52e-06	7.48e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	8.44e-06	7.41e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—TYK2—type 1 diabetes mellitus	8.42e-06	7.39e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	8.41e-06	7.38e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—NOS3—type 1 diabetes mellitus	8.41e-06	7.38e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	8.4e-06	7.37e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—NOS3—type 1 diabetes mellitus	8.4e-06	7.37e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	8.39e-06	7.37e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—INS—type 1 diabetes mellitus	8.29e-06	7.27e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	8.27e-06	7.26e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—NOS3—type 1 diabetes mellitus	8.26e-06	7.25e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—IL2—type 1 diabetes mellitus	8.26e-06	7.25e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	8.24e-06	7.23e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—CASP3—type 1 diabetes mellitus	8.23e-06	7.22e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	8.22e-06	7.21e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—IL2—type 1 diabetes mellitus	8.21e-06	7.21e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—IL6—type 1 diabetes mellitus	8.17e-06	7.17e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—STAT3—type 1 diabetes mellitus	8.08e-06	7.09e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.87e-06	6.91e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—IL2—type 1 diabetes mellitus	7.86e-06	6.9e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.82e-06	6.87e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.8e-06	6.84e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.66e-06	6.72e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—ALB—type 1 diabetes mellitus	7.6e-06	6.67e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—INS—type 1 diabetes mellitus	7.4e-06	6.49e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.34e-06	6.44e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—NOS3—type 1 diabetes mellitus	7.27e-06	6.38e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.26e-06	6.37e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—IL2—type 1 diabetes mellitus	7.25e-06	6.36e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.21e-06	6.33e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.14e-06	6.27e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IL2—type 1 diabetes mellitus	7.13e-06	6.26e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.13e-06	6.26e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IL2—type 1 diabetes mellitus	7.12e-06	6.25e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.1e-06	6.23e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.08e-06	6.21e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.01e-06	6.16e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IL2—type 1 diabetes mellitus	7e-06	6.15e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.99e-06	6.14e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IL2—type 1 diabetes mellitus	6.98e-06	6.13e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.97e-06	6.12e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.95e-06	6.1e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.95e-06	6.1e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.91e-06	6.07e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	6.8e-06	5.97e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—ALB—type 1 diabetes mellitus	6.78e-06	5.95e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—INS—type 1 diabetes mellitus	6.74e-06	5.92e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.62e-06	5.81e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—IL6—type 1 diabetes mellitus	6.56e-06	5.75e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—IL6—type 1 diabetes mellitus	6.55e-06	5.75e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.5e-06	5.7e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IL2—type 1 diabetes mellitus	6.49e-06	5.69e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—NOS3—type 1 diabetes mellitus	6.49e-06	5.69e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.46e-06	5.67e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	6.31e-06	5.54e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—EGFR—type 1 diabetes mellitus	6.28e-06	5.51e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	6.24e-06	5.47e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—ALB—type 1 diabetes mellitus	6.18e-06	5.43e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.1e-06	5.35e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—EGFR—type 1 diabetes mellitus	6.01e-06	5.28e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	6e-06	5.27e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.99e-06	5.26e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	5.97e-06	5.24e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—NOS3—type 1 diabetes mellitus	5.91e-06	5.19e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.89e-06	5.17e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.88e-06	5.16e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—INS—type 1 diabetes mellitus	5.76e-06	5.06e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—IL6—type 1 diabetes mellitus	5.64e-06	4.95e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.54e-06	4.87e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.46e-06	4.79e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.46e-06	4.79e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.44e-06	4.78e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.36e-06	4.7e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.34e-06	4.69e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—ALB—type 1 diabetes mellitus	5.28e-06	4.64e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—NOS3—type 1 diabetes mellitus	5.05e-06	4.43e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.96e-06	4.36e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—IL6—type 1 diabetes mellitus	4.85e-06	4.26e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—IL6—type 1 diabetes mellitus	4.83e-06	4.24e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—IL6—type 1 diabetes mellitus	4.62e-06	4.06e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—IL6—type 1 diabetes mellitus	4.26e-06	3.74e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IL6—type 1 diabetes mellitus	4.19e-06	3.68e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IL6—type 1 diabetes mellitus	4.18e-06	3.67e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IL6—type 1 diabetes mellitus	4.12e-06	3.61e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IL6—type 1 diabetes mellitus	4.11e-06	3.6e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IL6—type 1 diabetes mellitus	3.81e-06	3.35e-05	CbGpPWpGaD
